BACKGROUND: male breast cancer is uncommon and studies regarding the potential clinical relevance of the histopathological and immunohistochemical features are infrequently reported. MATERIALS AND METHODS: We investigated the biological characteristics of forty-one male patients with invasive breast cancer by assessing histopathological and multiple immunohistochemical features. RESULTS: The majority were no special type (ductal) (37/41), lobular cancer was not seen. 73% were histological grade 3, 93% were positive for oestrogen receptor and 73% for progesterone receptor. The proportion of cancers positive for c-ebB-2 (45%), EGFR (20%), p53 (58%), MiB1 (40%), NCRC11 (78%), were similar to reports for female breast cancer. Nonsignificant associations between poor survival outcome and grade 3 tumours, and positive tissue staining for MiB1 and p53 were seen. CONCLUSION: While there ar similarities in the biological features of breast cancer in males and females, some differences were identified. Male breast cancer is more likely to be grade 3 tumours and hormone receptor positive.
BACKGROUND:male breast cancer is uncommon and studies regarding the potential clinical relevance of the histopathological and immunohistochemical features are infrequently reported. MATERIALS AND METHODS: We investigated the biological characteristics of forty-one male patients with invasive breast cancer by assessing histopathological and multiple immunohistochemical features. RESULTS: The majority were no special type (ductal) (37/41), lobular cancer was not seen. 73% were histological grade 3, 93% were positive for oestrogen receptor and 73% for progesterone receptor. The proportion of cancers positive for c-ebB-2 (45%), EGFR (20%), p53 (58%), MiB1 (40%), NCRC11 (78%), were similar to reports for female breast cancer. Nonsignificant associations between poor survival outcome and grade 3 tumours, and positive tissue staining for MiB1 and p53 were seen. CONCLUSION: While there ar similarities in the biological features of breast cancer in males and females, some differences were identified. Male breast cancer is more likely to be grade 3 tumours and hormone receptor positive.
Authors: Nick Orr; Rosie Cooke; Michael Jones; Olivia Fletcher; Frank Dudbridge; Sarah Chilcott-Burns; Katarzyna Tomczyk; Peter Broderick; Richard Houlston; Alan Ashworth; Anthony Swerdlow Journal: PLoS Genet Date: 2011-09-15 Impact factor: 5.917
Authors: Yimin Ge; Nour Sneige; Mahmoud A Eltorky; Zhiqin Wang; E Lin; Yun Gong; Ming Guo Journal: Breast Cancer Res Date: 2009-05-14 Impact factor: 6.466
Authors: Jeroen F Vermeulen; Robert Kornegoor; Elsken van der Wall; Petra van der Groep; Paul J van Diest Journal: PLoS One Date: 2013-01-04 Impact factor: 3.240
Authors: Fatih Selcukbiricik; Deniz Tural; Fatih Aydoğan; Nuran Beşe; Evin Büyükünal; Süheyla Serdengeçti Journal: J Breast Cancer Date: 2013-03-31 Impact factor: 3.588
Authors: Kaiyumars B Contractor; Kanchan Kaur; Gabriel S Rodrigues; Dhananjay M Kulkarni; Hemant Singhal Journal: World J Surg Oncol Date: 2008-06-16 Impact factor: 2.754